Jeffrey Krempec, MD
Adult Reconstructive Orthopaedic Surgery · Kansas City, MONPI 1043340854
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 97.6% of it on its own, with 3 other manufacturers making up the rest.
Across 38 payments — averaging $1007.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$37K
- KCI USA, Inc.$800
- Bone Support Inc.$80
- Heron Therapeutics, Inc.$25
Across 2 payments — averaging $5287.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$11K
What the payments were for
- Consulting fees$18,18848%
- Speaking & faculty fees$12,93834%
- Travel & lodging$5,67915%
- Food & beverage$1,4774%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 35 | $37,375 |
| KCI USA, Inc. | 1 | $800 |
| Bone Support Inc. | 1 | $80 |
| Heron Therapeutics, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$43,324
- REAL INTELLIGENCE$15,199
- Journey II XR$12,488
- LEGION TKS$8,515
- REDAPT$8,480
- Legion$2,760
- Journey II BCS$1,920
- Journey II CR$1,920
- VISIONAIRE FastPak$1,920
- Legion Revision$1,840
- POLARSTEM$1,233
- RI.HIP NAVIGATION$1,200
- PREVENA$800
- Anthology$634
- R3 ACETABULAR$293
How this compares
$38,280 in reported general payments places this provider in the 70th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.
See all adult reconstructive orthopaedic surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 230 | $7,672 |
| Oxycodone Hcl | 381 | $2,596 |
| Gabapentin | 261 | $2,509 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 258 | $2,496 |
| Tramadol Hcl | 98 | $326 |
| Ondansetron OdtOndansetron | 17 | $267 |
| Pregabalin | 11 | $245 |
| Amoxicillin | 237 | $182 |
| Meloxicam | 51 | $112 |
| Cephalexin | 15 | $79 |
| Clindamycin Hcl | 65 | $77 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Kansas City
- John EggersKansas City$6K
- Danny GurbaKansas City$40
- Robert BarrackSaint Louis$10.6M
- Ryan NunleySaint Louis$3.9M
- Thomas AletoColumbia$669K
- John ClohisySaint Louis$538K
- Kimberly BartosiakSaint Louis$92K
- Ajay AggarwalColumbia$78K
- Ilya BendichSaint Louis$78K
- Muyibat AdelaniSaint Louis$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.